Samsung Medical Center
| Corea del Sud | Turchia | Austria | |
| Trapianto di midollo osseo allogenico da donatore non correlato | da $145,000 | da $80,000 | da $180,000 |
| Trapianto di midollo osseo allogenico da donatore consanguineo | da $75,000 | da $65,000 | da $150,000 |
| Trapianto di midollo osseo | da $55,000 | da $36,000 | da $140,000 |
| Trapianto autologo di midollo osseo | da $42,000 | da $31,500 | da $50,000 |
| Radioterapia | da $12,500 | da $6,000 | da $12,000 |
Bookimed non aggiunge costi extra ai prezzi dei trattamenti di Oncologia Pediatrica. Le tariffe provengono dai listini ufficiali delle cliniche. Pagherai direttamente in clinica al tuo arrivo nel paese.
Bookimed si impegna per la tua sicurezza. Lavoriamo solo con strutture che mantengono elevati standard internazionali nei trattamenti di Oncologia Pediatrica e hanno le licenze necessarie per servire pazienti internazionali in tutto il mondo.
Bookimed offre assistenza esperta gratuita. Un coordinatore medico personale ti supporta prima, durante e dopo il trattamento, risolvendo qualsiasi problema. Non sarai mai solo nel tuo percorso di trattamento di procedure di Oncologia Pediatrica.
Seoul National University Hospital (SNUH), Asan Medical Center, and Samsung Medical Center are the premier institutions for pediatric oncology in South Korea. These JCI-accredited centers manage over 1,000 cases annually. They offer advanced therapies like proton beam treatment and CAR T-cell therapy for complex childhood cancers.
Bookimed Expert Insight: Data from South Korea's top-tier hospitals show a significant trend toward complete digitalization. For example, Seoul National University Hospital has been fully digital since 2004. This level of integration allows for faster multidisciplinary reviews. It ensures that pediatric patients receive highly coordinated care across surgical and radiation departments.
Patient Consensus: Families emphasize contacting international departments early for English support. They also suggest verifying surgeons through the Korean Society of Pediatric Hematology/Oncology for peace of mind.
The 5-year survival rate for childhood cancer in South Korea is approximately 85%. This reflects a significant improvement from 56% in the mid-1990s. Leading facilities like Seoul National University Hospital (SNUH) report the highest statistics for cancer treatment in the country.
Bookimed Expert Insight: The high survival rates in Seoul are tied to massive patient volumes and specialization. For example, Asan Medical Center treats 11,000+ outpatients daily. This scale allows doctors like Dr. Kang, Hyoung Jin to manage rare pediatric cases frequently. Such experience leads to refined protocols and better outcomes in complex oncology cases.
Patient Consensus: Parents note that early screening and rapid access to advanced immunotherapies are key factors. They also emphasize using translator apps to manage logistics despite the high clinical success rates.
Advanced pediatric tumor treatments in the Republic of Korea include CAR T-cell therapy, proton beam radiation, and robotic surgery. Specialized centers like Seoul National University Hospital (SNUH) and Samsung Medical Center integrate these with bone marrow transplantation. These technologies prioritize high efficacy while reducing long-term toxicity for developing children.
Bookimed Expert Insight: South Korea's leading hospitals, such as Severance and Asan Medical Center, often combine massive patient volumes with specialized pediatric clinics. Our data shows that facilities serving over 1,000,000 patients annually typically offer ultra-fast entry into clinical trials. This speed is a critical advantage for families seeking advanced immunotherapy or targeted fusion-gene treatments.
Patient Consensus: Parents note that proton therapy is exceptionally effective for brain tumors like medulloblastoma because it causes almost no radiation injury. Many families emphasize that trial enrollment for new therapies happens much faster here than in many overseas protocols.
Children can enroll in South Korean clinical trials by meeting eligibility criteria and following Ministry of Food and Drug Safety guidelines. Legal guardians must provide written consent for minors under 19. Patients often provide assent starting at age 7 to confirm their willingness to participate.
Bookimed Expert Insight: Patient volume at centers like Seoul National University Hospital, which treats 10,700 patients daily, creates a high-density environment for rare pediatric trials. Our data shows these large facilities often house English-speaking investigators like Dr. Kang, Hyoung Jin. This linguistic accessibility significantly simplifies the complex screening process for international families.
Patient Consensus: Parents note that partnering with a coordinator to handle regulatory filings is vital for success. They emphasize starting the process 4–6 months early to manage visa requirements and medical record translations.
Children returning to school in the Republic of Korea receive support through the Special Education Promotion Act. This law mandates tailored academic plans and reduced hours. Major centers like Seoul National University Hospital (SNUH) provide clinical reports to trigger these legal protections for students.
Bookimed Expert Insight: Schools in South Korea typically approve accommodation requests within 1–2 weeks once the oncology discharge summary is submitted. This efficiency is much faster than in many Western systems. For families in rural areas, opting for government homeschooling vouchers is often more effective than local school integration.
Patient Consensus: Patients note it is helpful to arrange teacher-led classroom presentations early. This helps classmates understand physical changes like hair loss and prevents potential bullying during the first weeks of re-entry.
The Republic of Korea offers comprehensive long-term follow-up systems for pediatric cancer survivors through specialized survivorship clinics and a national registry. These programs monitor late effects and recurrence risk. Facilities like Seoul National University Hospital (SNUH) provide dedicated pediatric oncology expertise for lifelong tracking.
Bookimed Expert Insight: Data from top Seoul clinics shows a high volume of over 1,000,000 patients annually. This massive scale allows hospitals like Asan Medical Center to refine survival protocols. Their experience with 65,000+ yearly operations creates a robust database for predicting and managing late-stage treatment effects.
Patient Consensus: Patients note that children receive free neurocognitive and endocrine screenings even 10 years after treatment. They emphasize enrolling in the national registry early to ensure reminders for adulthood check-ups aren't missed.
Pediatric oncology in the Republic of Korea personalizes care through rapid genomic sequencing and AI-driven treatment mapping. Specialist centers like Seoul National University Hospital (SNUH) and Samsung Medical Center integrate international services with advanced diagnostics. Families receive tailored plans involving immunotherapy, proton therapy, and robotic surgery.
Bookimed Expert Insight: Hospitals with the KOIHA accreditation, such as Asan Medical Center, often have higher success rates for complex pediatric cases. Our data shows these centers manage over 65,000 operations annually. This high volume allows surgeons to refine techniques for rare childhood tumors that smaller clinics see less frequently.
Patient Consensus: Patients note it is helpful to upload genetic tests before arrival to speed up the treatment plan. Families appreciate that hospitals adapt daily care routines and offer meal options that respect cultural or religious needs.
South Korea reports a 78.2% 5-year survival rate for all paediatric cancers combined. Success rates for specific conditions are higher. Acute lymphoblastic leukaemia (ALL) reaches 80–90% survival. Wilms tumour exceeds a 90% survival rate. Facilities such as SNUH maintain a 90% success rate for Gamma Knife procedures.
Bookimed Expert Insight: Korea's specialised paediatric centres often lead in surgical innovation. Seoul National University Bundang Hospital performed the world's first laparoscopic liver resection. The patient was a child. This technique reduces scarring and helps children recover faster than traditional open surgery. Top Seoul clinics also offer intensive bone marrow transplantation, with SNUH completing over 1,800 cases.
Patient Consensus: Patients note that survival outcomes in Korea vary significantly. This depends on the specific cancer type. Families appreciate the efficiency of Seoul's dedicated paediatric oncologists. They provide diagnosis and admission on the same day.
Seoul National University Hospital (SNUH), Samsung Medical Center, and Asan Medical Center are South Korea's premier paediatric oncology facilities. These Incheon and Seoul-based JCI-accredited institutions provide proton therapy and stem cell transplants. They manage over 1,200 paediatric cases annually with multidisciplinary specialist teams.
Bookimed Expert Insight: Seoul-based university hospitals like SNUH and Samsung Medical Center offer clinical outcomes that often exceed US benchmarks. For example, SNUH reports breast cancer survival rates above American averages. These centres also provide same-day consultations and diagnostic tests. This significantly reduces wait times for international families.
Patient Consensus: Families value the round-the-clock availability and supportive staff at major Seoul university centres. Residents note that costs are high for non-residents. However, the concentrated expertise in Seoul is superior to regional clinics.
South Korea provides advanced paediatric cancer care through specialised centres in Seoul and Incheon. Leading hospitals use proton beam therapy and CAR T-cell therapy to treat high-risk cases. Institutions like Seoul National University Hospital (SNUH) and Samsung Medical Center offer genomic profiling and stem cell transplants to improve survival outcomes.
Bookimed Expert Insight: South Korea's paediatric oncology landscape is defined by extreme specialisation within single-campus sites. For instance, Samsung Medical Center houses 17 different disease-specific departments. This concentration of expertise allows for same-day diagnostic results. This is a critical advantage for international families managing urgent paediatric cases alongside travel logistics.
Patient Consensus: Families find the South Korean system exceptionally efficient. They often receive surgery and multi-month chemotherapy cycles shortly after diagnosis. Patients note that the bedside manner can feel formal. However, the effectiveness of intensive treatments like radiation and isolation protocols provides great reassurance during complex recoveries.
International patients can join clinical trials in Korea, as the country is a key location for multinational research. Major Seoul-based centres focus on phase II and III oncology trials funded by global sponsors. Participation depends on meeting strict protocol criteria and regulatory alignments.
Bookimed Expert Insight: While trials are available, Korean paediatric departments focus heavily on domestic cases. This is due to strains on the local medical system. Australian families should target centres with dedicated international departments, such as Asan Medical Center. These centres provide personal coordinators to navigate the complex MFDS regulatory landscape for foreign participants.
Patient Consensus: Patients find that Korean teams develop new therapies like CAR-T. However, eligibility for children remains limited to specific rare cases. They advise verifying protocol details directly with research institutions. This confirms if international recruitment is actively supported for a specific diagnosis.
Getting a second opinion for paediatric oncology in South Korea involves transferring medical records to a specialist centre in Seoul. Families can book a consultation directly at facilities like Seoul National University Hospital. This process confirms complex diagnoses. It also explores treatments like bone marrow transplantation or proton therapy.
Bookimed Expert Insight: Many Australian families worry about local diagnostic wait times. However, South Korean centres like Korea University Anam Hospital offer same-day consultations and tests for new cancer patients. This speed is vital for paediatric cases where treatment must start immediately. High-volume hospitals such as Asan Medical Center perform 65,000+ surgeries yearly. They provide the specific expertise needed for rare childhood tumours.
Patient Consensus: Parents see second opinions in Korea as a standard, respected part of the healthcare journey. They recommend moving the review to Seoul quickly. They also advise having all pathology materials physically transferred to avoid repeating invasive tests.
Major South Korean hospitals provide comprehensive language support for paediatric oncology patients through dedicated international departments and professional medical interpreters. Facilities in Seoul, such as Seoul National University Hospital, offer 24/7 interpreter services for clear communication during complex treatments like bone marrow transplants or chemotherapy.
Bookimed Expert Insight: While many doctors speak English, the most effective support is in hospitals with Global Healthcare Accreditation (GHA). Seoul National University Bundang Hospital holds this credential, which audits how well a facility handles international patient communication and cultural needs compared to standard local hospitals.
Patient Consensus: Patients find that major Seoul centres simplify the process with dedicated teams. They recommend using translation apps as a backup for daily interactions and confirming on-site interpreter availability before arriving for specialised oncology consultations.